Patent · US Active

Means and methods for treating and/or preventing natural AHR ligand-dependent cancer

US9593062B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignee

DEUTSCHLAND KREBSFORSCHUNGSZENTRUM · DE

Inventors

Michael Platten · Heidelberg, DE
Christiane Opitz · Weinheim, DE
Wolfgang Wick · Heidelberg, DE
Ulrike Litzenburger · Dossenheim, DE

Key dates

Filing date	Sep 7, 2012
Grant date	Mar 14, 2017
Priority date	—
Expiry date	Oct 6, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y113/11017
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the field of cancer therapeutics and treatment of cancer. In particular, it relates to a method for treating and/or preventing a natural AHR ligand-dependent cancer comprising administering to a subject suffering from said cancer a therapeutically effective amount of an AHR inhibitor. Moreover, contemplated is a AHR inhibitor for use in treating and/or preventing a natural AHR ligand-dependent cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.